Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(11)2021 Jun 01.
Article in English | MEDLINE | ID: mdl-34206089

ABSTRACT

Amyloid-ß (Aß) 1-40 and 1-42 peptides are key mediators of synaptic and cognitive dysfunction in Alzheimer's disease (AD). Whereas in AD, Aß is found to act as a pro-epileptogenic factor even before plaque formation, amyloid pathology has been detected among patients with epilepsy with increased risk of developing AD. Among Aß aggregated species, soluble oligomers are suggested to be responsible for most of Aß's toxic effects. Aß oligomers exert extracellular and intracellular toxicity through different mechanisms, including interaction with membrane receptors and the formation of ion-permeable channels in cellular membranes. These damages, linked to an unbalance between excitatory and inhibitory neurotransmission, often result in neuronal hyperexcitability and neural circuit dysfunction, which in turn increase Aß deposition and facilitate neurodegeneration, resulting in an Aß-driven vicious loop. In this review, we summarize the most representative literature on the effects that oligomeric Aß induces on synaptic dysfunction and network disorganization.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Peptides/genetics , Synapses/genetics , Synaptic Transmission/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/adverse effects , Amyloid beta-Peptides/ultrastructure , Amyloidogenic Proteins/adverse effects , Amyloidogenic Proteins/genetics , Animals , Humans , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Multimerization/genetics , Synapses/metabolism
2.
Int J Mol Sci ; 21(24)2020 Dec 15.
Article in English | MEDLINE | ID: mdl-33333996

ABSTRACT

At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and artificial origin to combat pathogens. AMPs have several points that determine their biological activity. We analyzed the structural properties of AMPs, as well as described their mechanism of action and impact on pathogenic bacteria and viruses. Recently published data on the development of new AMP drugs based on a combination of molecular design and genetic engineering approaches are presented. In this article, we have focused on information on the amyloidogenic properties of AMP. This review examines AMP development strategies from the perspective of the current high prevalence of antibiotic-resistant bacteria, and the potential prospects and challenges of using AMPs against infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


Subject(s)
Amyloidogenic Proteins/pharmacology , COVID-19 Drug Treatment , COVID-19/virology , Pore Forming Cytotoxic Proteins/pharmacology , SARS-CoV-2/drug effects , Amyloidogenic Proteins/adverse effects , Amyloidogenic Proteins/therapeutic use , Animals , Coronavirus Infections/drug therapy , Humans , Pore Forming Cytotoxic Proteins/adverse effects , Pore Forming Cytotoxic Proteins/therapeutic use , Proteome
3.
Neurobiol Aging ; 80: 196-202, 2019 08.
Article in English | MEDLINE | ID: mdl-31207551

ABSTRACT

Older adults with Down syndrome (DS) often have Alzheimer's disease (AD) neuropathologies. Although positron emission tomography imaging studies of amyloid deposition (beta amyloid, Aß) have been associated with worse clinical prognosis and cognitive impairment, their relationships with cortical thickness remain unclear in people with DS. In a sample of 44 DS adults who underwent cognitive assessments, [11C]-PiB positron emission tomography, and T1-weighted magnetization-prepared rapid gradient echo, we used mixed effect models to evaluate the spatial relationships between Aß binding with patterns of cortical thickness. Partial Spearman correlations were used to delineate the topography of local Aß-associated cortical thinning. [11C]-PiB nondisplaceable binding potential was negatively associated with decreased cortical thickness. Locally, regional [11C]-PiB retention was negatively correlated with cortical thickness in widespread cortices, predominantly in temporoparietal regions. Contrary to the prevailing evidence in established AD, we propose that our findings implicate Aß in spatial patterns of atrophy that recapitulated the "cortical signature" of neurodegeneration in AD, conferring support to recent recommendations for earlier disease-interventions.


Subject(s)
Amyloidogenic Proteins/adverse effects , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Down Syndrome/diagnostic imaging , Down Syndrome/pathology , Adult , Aged , Amyloid beta-Peptides , Atrophy , Diffusion Magnetic Resonance Imaging , Female , Humans , Male , Middle Aged , Positron-Emission Tomography
4.
Rev. bras. cir. plást ; 34(1): 73-78, jan.-mar. 2019. ilus, tab
Article in English, Portuguese | LILACS | ID: biblio-994548

ABSTRACT

Introdução: A amiloidose é caracterizada pela deposição de proteínas nos órgãos e tecidos, e tem sido associada à síndrome do túnel do carpo (STC) quando ocorre no punho. O objetivo é descrever uma série de casos de pacientes submetidos à cirurgia para STC associado à amiloidose. Métodos: O estudo incluiu 12 pacientes que se submeteram à cirurgia para tratar a STC cuja biópsia identificou amiloidose; o seguimento foi de cinco anos. Os pacientes foram avaliados por testes clínicos, eletroneuromiografia, imagens radiológicas e biópsia. Resultados: Todos os pacientes apresentaram queixas musculoesqueléticas, sintomas severos de compressão do nervo mediano, alterações nos testes neurofisiológicos. Realizou-se a cirurgia, sinovectomia e biópsia. No pós-operatório, cinco pacientes (41%) desenvolveram dor crônica e distrofia simpático-reflexa. Conclusão: Observou-se maior frequência de dor pós-operatória na amostra, o que revela a necessidade de atenção na abordagem e tratamento dessa associação.


Introduction: Amyloidosis features protein deposition in the organs and tissues and has been associated with carpal tunnel syndrome (CTS) when it occurs in the wrist. The objective is to describe a case series of patients undergoing surgery for CTS associated with amyloidosis. Methods: The study included 12 patients who underwent surgery to treat CTS in whom amyloidosis was proven by biopsy; the follow-up period was 5 years. The patients were evaluated by clinical tests, electroneuromyography, radiological images, and biopsy. Results: All patients presented with musculoskeletal complaints, severe symptoms of median nerve compression, and changes on neurophysiological tests. Surgery, synovectomy, and biopsy were performed. In the postoperative period, five patients (41%) developed chronic pain and reflex sympathetic dystrophy. Conclusion: A higher frequency of postoperative pain was observed in the patients, demonstrating the need for caution in the approach and treatment of this association.


Subject(s)
Humans , Postoperative Complications/rehabilitation , Postoperative Complications/therapy , Carpal Tunnel Syndrome/surgery , Carpal Tunnel Syndrome/therapy , Comprehensive Health Care/methods , Comprehensive Health Care/organization & administration , Orthopedic Procedures/adverse effects , Orthopedic Procedures/methods , Plastic Surgery Procedures/methods , Plastic Surgery Procedures/rehabilitation , Amyloidogenic Proteins/analysis , Amyloidogenic Proteins/adverse effects
5.
FEBS Lett ; 589(24 Pt B): 4033-8, 2015 Dec 21.
Article in English | MEDLINE | ID: mdl-26554815

ABSTRACT

Amyloid aggregates display striking features of detergent stability and self-seeding. Human serum albumin (HSA), a preferred drug-carrier molecule, can also aggregate in vitro. So far, key amyloid properties of stability against ionic detergents and self-seeding, are unclear for HSA aggregates. Precautions against amyloid contamination would be required if HSA aggregates were self-seeding. Here, we show that HSA aggregates display detergent sarkosyl stability and have self-seeding potential. HSA dimer is preferable for clinical applications due to its longer retention in circulation and lesser oedema owing to its larger molecular size. Here, HSA was homodimerized via free cysteine-34, without any potentially immunogenic cross-linkers that are usually pre-requisite for homodimerization. Alike the monomer, HSA dimers also aggregated as amyloid, necessitating precautions while using for therapeutics.


Subject(s)
Amyloidogenic Proteins/chemistry , Plasma Substitutes/chemistry , Serum Albumin/chemistry , Amyloidogenic Proteins/adverse effects , Amyloidogenic Proteins/genetics , Amyloidogenic Proteins/ultrastructure , Chromatography, Gel , Cysteine/chemistry , Detergents/chemistry , Dimerization , Drug Carriers , Humans , Hydrogen Peroxide/chemistry , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Molecular Weight , Oxidants/chemistry , Oxidation-Reduction , Plasma Substitutes/adverse effects , Protein Aggregation, Pathological/etiology , Protein Stability , Recombinant Proteins , Sarcosine/analogs & derivatives , Sarcosine/chemistry , Serum Albumin/adverse effects , Serum Albumin/genetics , Serum Albumin/ultrastructure , Serum Albumin, Human
6.
Biochim Biophys Acta ; 1832(12): 2302-14, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24075940

ABSTRACT

Although human transthyretin (TTR) is associated with systemic amyloidoses, an anti-amyloidogenic effect that prevents Aß fibril formation in vitro and in animal models has been observed. Here we studied the ability of three different types of TTR, namely human tetramers (hTTR), mouse tetramers (muTTR) and an engineered monomer of the human protein (M-TTR), to suppress the toxicity of oligomers formed by two different amyloidogenic peptides/proteins (HypF-N and Aß42). muTTR is the most stable homotetramer, hTTR can dissociate into partially unfolded monomers, whereas M-TTR maintains a monomeric state. Preformed toxic HypF-N and Aß42 oligomers were incubated in the presence of each TTR then added to cell culture media. hTTR, and to a greater extent M-TTR, were found to protect human neuroblastoma cells and rat primary neurons against oligomer-induced toxicity, whereas muTTR had no protective effect. The thioflavin T assay and site-directed labeling experiments using pyrene ruled out disaggregation and structural reorganization within the discrete oligomers following incubation with TTRs, while confocal microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers and hTTR, particularly M-TTR. Moreover, atomic force microscopy (AFM), light scattering and turbidimetry analyses indicated that larger assemblies of oligomers are formed in the presence of M-TTR and, to a lesser extent, with hTTR. Overall, the data suggest a generic capacity of TTR to efficiently neutralize the toxicity of oligomers formed by misfolded proteins and reveal that such neutralization occurs through a mechanism of TTR-mediated assembly of protein oligomers into larger species, with an efficiency that correlates inversely with TTR tetramer stability.


Subject(s)
Amyloid beta-Peptides/adverse effects , Amyloidogenic Proteins/adverse effects , Carboxyl and Carbamoyl Transferases/adverse effects , Escherichia coli Proteins/adverse effects , Neuroblastoma/drug therapy , Neurons/drug effects , Prealbumin/pharmacology , Protein Folding/drug effects , Animals , Calcium/metabolism , Cells, Cultured , Humans , In Vitro Techniques , Mice , Microscopy, Atomic Force , Models, Molecular , Neuroblastoma/metabolism , Neuroblastoma/pathology , Neurons/metabolism , Neurons/pathology , Protein Conformation , Protein Multimerization , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...